Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Squamous Cell | 1 | 2022 | 651 | 0.580 |
Why?
|
| Adenocarcinoma | 2 | 2022 | 993 | 0.570 |
Why?
|
| Diverticulum, Colon | 1 | 2014 | 4 | 0.470 |
Why?
|
| Adenomatous Polyps | 1 | 2014 | 13 | 0.460 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 935 | 0.430 |
Why?
|
| Veterans | 4 | 2022 | 1726 | 0.420 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2022 | 115 | 0.420 |
Why?
|
| Colonic Polyps | 1 | 2014 | 78 | 0.410 |
Why?
|
| Colonoscopy | 1 | 2014 | 239 | 0.390 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 1308 | 0.380 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 245 | 0.380 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 183 | 0.330 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2023 | 55 | 0.330 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 178 | 0.330 |
Why?
|
| Bronchoscopy | 3 | 2015 | 158 | 0.330 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2011 | 145 | 0.320 |
Why?
|
| Duodenum | 2 | 2020 | 97 | 0.300 |
Why?
|
| Lung | 3 | 2011 | 1475 | 0.280 |
Why?
|
| Middle Aged | 18 | 2022 | 25994 | 0.250 |
Why?
|
| Influenza, Human | 1 | 2011 | 649 | 0.240 |
Why?
|
| Plasma Cells | 1 | 2025 | 54 | 0.240 |
Why?
|
| Mediastinal Diseases | 1 | 2003 | 14 | 0.230 |
Why?
|
| Mammary Analogue Secretory Carcinoma | 1 | 2023 | 8 | 0.220 |
Why?
|
| Rhabdomyoma | 1 | 2003 | 16 | 0.210 |
Why?
|
| Antigens, Neoplasm | 1 | 2025 | 387 | 0.200 |
Why?
|
| Scalp | 1 | 2022 | 56 | 0.200 |
Why?
|
| Mouth Neoplasms | 1 | 2003 | 82 | 0.200 |
Why?
|
| Male | 22 | 2022 | 60079 | 0.190 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 332 | 0.190 |
Why?
|
| Precancerous Conditions | 2 | 2014 | 287 | 0.180 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 1582 | 0.180 |
Why?
|
| Carcinoma | 1 | 2023 | 278 | 0.180 |
Why?
|
| Cell Degranulation | 1 | 2020 | 29 | 0.180 |
Why?
|
| Neoplasm Proteins | 1 | 2025 | 667 | 0.180 |
Why?
|
| Barrett Esophagus | 2 | 2014 | 340 | 0.170 |
Why?
|
| Eosinophils | 1 | 2020 | 121 | 0.170 |
Why?
|
| Dyspepsia | 1 | 2020 | 101 | 0.170 |
Why?
|
| Eosinophilia | 1 | 2020 | 101 | 0.160 |
Why?
|
| Endoscopy, Digestive System | 2 | 2016 | 153 | 0.150 |
Why?
|
| Humans | 27 | 2025 | 123166 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 2056 | 0.150 |
Why?
|
| Emphysema | 2 | 2009 | 66 | 0.140 |
Why?
|
| Biopsy, Needle | 4 | 2013 | 229 | 0.140 |
Why?
|
| Granuloma, Giant Cell | 1 | 2015 | 13 | 0.130 |
Why?
|
| Celiac Disease | 1 | 2016 | 68 | 0.130 |
Why?
|
| Salivary Glands, Minor | 1 | 2015 | 10 | 0.120 |
Why?
|
| Bone Marrow Diseases | 1 | 2015 | 40 | 0.120 |
Why?
|
| Public Health Surveillance | 1 | 2015 | 37 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 35 | 0.120 |
Why?
|
| Klatskin Tumor | 1 | 2014 | 5 | 0.120 |
Why?
|
| Endosonography | 1 | 2015 | 82 | 0.120 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2015 | 41 | 0.120 |
Why?
|
| Hernia, Hiatal | 1 | 2014 | 54 | 0.120 |
Why?
|
| Fatal Outcome | 2 | 2014 | 356 | 0.110 |
Why?
|
| Splenic Neoplasms | 1 | 2014 | 11 | 0.110 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2014 | 95 | 0.110 |
Why?
|
| Leukocytosis | 1 | 2014 | 42 | 0.110 |
Why?
|
| Female | 12 | 2022 | 65499 | 0.110 |
Why?
|
| Hemangiosarcoma | 1 | 2014 | 38 | 0.110 |
Why?
|
| Gastritis | 1 | 2017 | 370 | 0.110 |
Why?
|
| Bile Duct Neoplasms | 1 | 2014 | 109 | 0.110 |
Why?
|
| Cholangiocarcinoma | 1 | 2014 | 107 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 288 | 0.110 |
Why?
|
| Lymph Nodes | 1 | 2015 | 375 | 0.100 |
Why?
|
| Esophagoscopy | 1 | 2013 | 156 | 0.100 |
Why?
|
| Gout | 1 | 2015 | 146 | 0.100 |
Why?
|
| Tracheal Neoplasms | 1 | 2012 | 21 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 228 | 0.100 |
Why?
|
| Neurilemmoma | 1 | 2012 | 46 | 0.100 |
Why?
|
| Overweight | 1 | 2014 | 357 | 0.100 |
Why?
|
| Debridement | 1 | 2012 | 85 | 0.100 |
Why?
|
| Gastroesophageal Reflux | 1 | 2014 | 289 | 0.100 |
Why?
|
| Aged | 11 | 2020 | 19080 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2015 | 482 | 0.090 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 1213 | 0.090 |
Why?
|
| Lymphatic Metastasis | 3 | 2023 | 400 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2022 | 16021 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 617 | 0.090 |
Why?
|
| Aspartate Aminotransferases | 1 | 2010 | 76 | 0.080 |
Why?
|
| Anemia | 1 | 2014 | 340 | 0.080 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 77 | 0.080 |
Why?
|
| Alanine Transaminase | 1 | 2010 | 151 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 359 | 0.080 |
Why?
|
| Smoking | 3 | 2014 | 1031 | 0.080 |
Why?
|
| Motor Activity | 1 | 2010 | 522 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 1687 | 0.070 |
Why?
|
| Elastin | 1 | 2007 | 32 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2009 | 403 | 0.070 |
Why?
|
| Hepatitis C, Chronic | 1 | 2010 | 323 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2007 | 172 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2010 | 365 | 0.060 |
Why?
|
| Biomarkers, Tumor | 2 | 2023 | 1430 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2010 | 695 | 0.060 |
Why?
|
| Helicobacter Infections | 1 | 2014 | 1256 | 0.060 |
Why?
|
| Logistic Models | 2 | 2014 | 1793 | 0.060 |
Why?
|
| Macrophages, Alveolar | 1 | 2004 | 43 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 6371 | 0.060 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2003 | 11 | 0.060 |
Why?
|
| Gingiva | 1 | 2023 | 9 | 0.060 |
Why?
|
| Th1 Cells | 1 | 2004 | 152 | 0.060 |
Why?
|
| Fiber Optic Technology | 1 | 2003 | 46 | 0.060 |
Why?
|
| Mediastinal Neoplasms | 1 | 2003 | 39 | 0.050 |
Why?
|
| Pulmonary Emphysema | 1 | 2004 | 94 | 0.050 |
Why?
|
| Gene Fusion | 1 | 2023 | 55 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2025 | 269 | 0.050 |
Why?
|
| Lymphangioma | 1 | 2003 | 22 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 714 | 0.050 |
Why?
|
| Breast Neoplasms, Male | 1 | 2002 | 15 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2002 | 37 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2020 | 4706 | 0.050 |
Why?
|
| Hemangioma | 1 | 2003 | 95 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2023 | 757 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2023 | 197 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2007 | 596 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 2023 | 352 | 0.050 |
Why?
|
| Sex Factors | 2 | 2014 | 1259 | 0.040 |
Why?
|
| United States | 4 | 2020 | 10631 | 0.040 |
Why?
|
| Prevalence | 2 | 2017 | 2406 | 0.040 |
Why?
|
| Adult | 7 | 2017 | 29061 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2013 | 1243 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 3378 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3273 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2002 | 426 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 586 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1877 | 0.040 |
Why?
|
| Risk Factors | 3 | 2017 | 10010 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1265 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 2016 | 158 | 0.030 |
Why?
|
| Ethmoid Bone | 1 | 2015 | 8 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 5047 | 0.030 |
Why?
|
| Maxilla | 1 | 2015 | 36 | 0.030 |
Why?
|
| Uric Acid | 1 | 2015 | 94 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2014 | 55 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 142 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2016 | 354 | 0.030 |
Why?
|
| Time Factors | 2 | 2014 | 6217 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2014 | 47 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 354 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2015 | 323 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 2106 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 279 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 603 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 271 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 424 | 0.030 |
Why?
|
| Proton Pump Inhibitors | 1 | 2014 | 254 | 0.020 |
Why?
|
| Biopsy | 1 | 2015 | 1237 | 0.020 |
Why?
|
| Coffee | 1 | 2010 | 24 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2013 | 467 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 1309 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 601 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2010 | 176 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2009 | 118 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 386 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1117 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2009 | 330 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2830 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 17491 | 0.020 |
Why?
|
| Registries | 1 | 2014 | 1392 | 0.020 |
Why?
|
| Anticholesteremic Agents | 1 | 2010 | 230 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2802 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 3047 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2007 | 216 | 0.020 |
Why?
|
| Helicobacter pylori | 1 | 2014 | 1314 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2004 | 20 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2004 | 38 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 44 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2004 | 39 | 0.010 |
Why?
|
| Chemokine CXCL10 | 1 | 2004 | 54 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 3316 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2007 | 518 | 0.010 |
Why?
|
| Animals | 1 | 2025 | 33746 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 1401 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 1734 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2002 | 113 | 0.010 |
Why?
|
| Antigens, Nuclear | 1 | 2002 | 61 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 3666 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 614 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 1285 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 1677 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 2025 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 1414 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2002 | 1870 | 0.010 |
Why?
|
| Adolescent | 1 | 2002 | 19103 | 0.000 |
Why?
|